microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in ...
Recommend Documents
teniposide (6). Currently, there is no effective chemotherapy available for the treatment of unresectable OSCC. Therefore, there is a need to identify potential ...
Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed to determine the expression level of miR-26b in 38 breast cancer ...
Nov 25, 2018 - Page 1 .... (Invitrogen, CA, USA) according to the manufacturer's pro- tocol with 50 pmol/ml .... Values were presented as the means ± standard deviation. (SD) from ..... American Journal of Translational Research, vol. 9, no.
Apr 21, 2011 - Kim,V.N. (2004) MicroRNA precursors in motion: exportin-5 mediates their .... Nagel,R., Clijsters,L. and Agami,R. (2009) the miRNA-192/194.
Jiwei Zhang1, Zehua Bian1, Jialiang Zhou2, Mingxu Song1, Zhihui Liu1, Yuyang Feng1, ...... Li T, Lu YY, Zhao XD, Guo HQ, Liu CH, Li H, Zhou L, Han YN, Wu.
Jun 15, 2012 - smooth muscle cell proliferation and the intervention function of Rosuvastatin, and clarify the mechanism and intervention manner of.
miR-183 expression levels of gastric cancer cell lines and ... microRNAs (miRNAs/miRs) are a group of small ..... the polycomb group protein EZH2 in cancer.
The growth, tumorigenicity, migration and ... Cell Counting Kit-8 (CCK-8), soft agar colony formation ... into papillary thyroid carcinoma K1 cells suppressed the.
ment of breast cancer, also has a beneficial effect on cisplatin- refractory ovarian .... p38 cascade in two human ovarian cancer cell lines: cisplatin- resistant ...
1Laboratory of Neuro-Oncology, Tianjin Neurological Institute; 2Key Laboratory of ... surgery, Tianjin Medical University General hospital, 154 An-Shan. Road ...
May 18, 2012 - body weights of 24.660.5 g (Huh7; p.0.05) and 26.660.8 g .... It is unknown whether ICD can suppress the tumorigenicity of. CD133+ HCC cells.
Abstract. Although surgical resection is the first choice for oral cancer, the development of new anti-cancer drugs is of great interest. The effect of the histone ...
kinase 1 (MAP3K7) binding protein 1 (TAB1) were direct targets of miR-873 in CRC cells. A luciferase assay revealed that ectopic expression of miRâ873 ...
Jul 4, 2016 - Comprehensive Cancer Center, University of California, Los Angeles, ... Biochemistry, The Jonsson Comprehensive Cancer Center and The ...
Jul 21, 2014 - length, 14 µl volume, 40-bar maximum pressure), and G2220AA 2D-Value Solution ChemStation software ...... [26] Choi, H.S., Seo, H.S., Kim, J.H., Um, J.Y., Shin, Y.C. and Ko, ... [email protected] or Online Submission Portal.
INTRODUCTION. 1,25-(OH)2 vitamin D3 [1,25(OH)2D3], the active metabolite of vitamin D, inhibits proliferation of a variety of tumor cells including prostate.
Aug 12, 2017 - Lung Cancer Cell Lines A549 and H460 by Inducing ... These authors contributed equally to this work. ... Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related ... drug resistance of docetaxel or cisplatin, there is an
Mar 28, 2018 - Xiaojun Xu1â¯, Xiaoyuan Liu2â¯, Yan Zhang3* ... erty in various kinds of cancers such as ovarian cancer [10], lung cancer [11,12], sarcoma [13],.
Curcumin inhibits the proliferation of a human colorectal cancer cell line Caco-2 partially by both apoptosis and G2/M cell cycle arrest. Satoru Sakuma, Chisato ...
Keywords: Circular RNA_LARP4, miR-424-5p, LATS1, Invasion, Gastric cancer ... miR-135b, miR-31 and miR-181c function as oncogenes boosting tumor ...
or anaplastic thyroid carcinoma (UTCs) are higly aggressive but extremely rare.16 Papillary thyroid carcinoma comprises more than. 80% of thyroid epithelial ...
A3 adenosine receptor (A3AR) agonists have been reported to modulate cellular proliferation. This work was aimed to investi- gate the expression and the ...
ONCOLOGY LETTERS 5: 1010-1016, 2013. 1010. Abstract. Transient receptor potential melastatin 7 (TRPM7), a Ca2+-permeable channel, has been ...
Dec 7, 2009 - lated by miR-129 (EASE score, 1.32E-2), including positive reg- ulators of cell death, such as Cdkn1a or p21, Inhba, Gadd45a,. Pdcd4, Braf ...
microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in ...
Abstract. Our recent study of the microRNA (miRNA) expression signature of hypopharyngeal squamous cell carcinoma (HSCC) revealed that microRNA-504 ...
INTERNATIONAL JOURNAL OF ONCOLOGY 44: 2085-2092, 2014
microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma NAOKO KIKKAWA1,2*, TAKASHI KINOSHITA1,2*, NIJIRO NOHATA1,2, TOYOYUKI HANAZAWA2, NORIKO YAMAMOTO1, ICHIRO FUKUMOTO1, TAKESHI CHIYOMARU3, HIDEKI ENOKIDA3, MASAYUKI NAKAGAWA3, YOSHITAKA OKAMOTO2 and NAOHIKO SEKI1 Departments of 1Functional Genomics and 2Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba; 3Department of Urology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan Received January 7, 2014; Accepted February 28, 2014 DOI: 10.3892/ijo.2014.2349 Abstract. Our recent study of the microRNA (miRNA) expression signature of hypopharyngeal squamous cell carcinoma (HSCC) revealed that microRNA-504 (miR-504) is significantly downregulated in HSCC tissues, suggesting that this miRNA is a candidate tumor suppressor. However, several previous reports indicated that miR-504 has an oncogenic function through targeting TP53. The aim of this study was to investigate the functional significance of miR-504 in cancer cells and to identify novel targets regulated by this miRNA in HSCC cells. First, we confirmed the downregulation of miR-504 in HSCC clinical specimens (P
